Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors

被引：50

作者：

Ogo, Naohisa

Oishi, Shinya

Matsuno, Kenji

Sawada, Jun-ichi

Fujii, Nobutaka

Asai, Akira

机构：

[1] Univ Shizuoka, Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 422, Japan

[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 606, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 14期

关键词：

S-trityl-L-cysteine; mitotic kinesin; Eg5; inhibitor; anticancer;

D O I：

10.1016/j.bmcl.2007.04.101

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3921 / 3924

页数：4

共 50 条

[41] S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression
Skoufias, Dimitrios A.
DeBonis, Salvatore
Saoudi, Yasmina
Lebeau, Luc
Crevel, Isabelle
Cross, Robert
Wade, Richard H.
Hackney, David
Kozielski, Frank
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (26) : 17559 - 17569
[42] Inhibitors of human mitotic kinesin Eg5: Characterization of the 4-phenyltetrahydroisoquinoline lead series.
Tarby, CM
Kaltenbach, RF
Huynh, T
Pudzianowski, A
Shen, H
Ortega-Nanos, M
Sheriff, S
Newitt, JA
McDonnell, PA
Mueller, L
Burford, N
Spicer, TP
O'Connell, J
Duke, GJ
Fairchild, CR
Peterson, RW
Johnston, K
Lewin, A
Chen, Z
Vaccaro, W
Poss, M
Naglich, J
Lombardo, LJ
Gottardis, M
Trainor, GL
Roussell, DL
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9052S - 9053S
[43] Evaluating Phenyl Propanoids Isolated from Citrus Medica as Potential Inhibitors for Mitotic kinesin Eg5
Makala, Himesh
Ulaganathan, Venkatasubramanian
Sivasubramanian, Aravind
Rajendran, Narendran
Subramanian, Shankar
LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (11) : 1355 - 1363
[44] The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5
Barsanti, Paul A.
Wang, Weibo
Ni, Zhi-Jie
Duhl, David
Brammeier, Nathan
Martin, Eric
Bussiere, Dirksen
Walter, Annette O.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 157 - 160
[45] Binding patterns of inhibitors to different pockets of kinesin Eg5
Jia, Ning
Zhang, Bingbing
Huo, Ziling
Qin, Jingyu
Ji, Qing
Geng, Yizhao
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 756
[46] Inhibitors of human mitotic kinesin Eg5: Characterization of the 4-phenyl-tetrahydrolsoquinoline lead series
Tarby, CM
Kaltenbach, RF
Huynh, T
Pudzianowski, A
Shen, H
Ortega-Nanos, M
Sheriff, S
Newitt, JA
McDonnell, PA
Burford, N
Fairchild, CR
Vaccaro, W
Chen, Z
Borzilleri, RM
Naglich, J
Lombardo, LJ
Gottardis, M
Trainor, GL
Roussell, DL
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2095 - 2100
[47] Biochemical and Biophysical characterization of curcumin binding to human mitotic kinesin Eg5: Insights into the inhibitory mechanism of curcumin on Eg5
Raghav, Darpan
Sebastian, Jomon
Rathinasamy, Krishnan
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 109 : 1189 - 1208
[48] 3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking
Luo, Xingyan
Shu, Mao
Wang, Yuanqiang
Liu, Jin
Yang, Wenjuan
Lin, Zhihua
MOLECULES, 2012, 17 (02) : 2015 - 2029
[49] Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein
Tanja Peters
Heike Lindenmaier
Walter E. Haefeli
Johanna Weiss
Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 372 : 291 - 299
[50] Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein
Peters, T
Lindenmaier, H
Haefeli, W
Weiss, J
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 (04) : 291 - 299

← 1 2 3 4 5 →